I think Treanda also looks good in refractory MM. In small cap biotech KERX/perifosine is currently in a phase 3 trial, under an SPA in relapsed/refractory MM.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.